Polyclonal evolution of lymphoproliferative disorders in XLP1

Dan Tomomasa1, Akira Nishimura1, Kenichi Yoshida2

  • 1Department of Pediatrics and Developmental Biology, Institute of Science Tokyo, Tokyo, Japan.

Journal of Human Immunity
|May 22, 2026
PubMed
Summary

X-linked lymphoproliferative syndrome type 1 (XLP1) may arise from polyclonal lymphocyte expansion, with or without Epstein-Barr virus (EBV). This can progress to malignancy through acquired genetic variants, impacting immune deficiency research.